Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Testa

Showing results (191-200 of 588) with videos related to

Pageof 59
Sort By:
Pediatrics|December 1, 1984
Acquired chromosome rearrangements, including fine interstitial deletions, in a patient with Down syndrome and monoblastic leukemiaS Misawa, J R Testa, L C Strauss, et al.
Abdominal Imaging|May 1, 1994
Usefulness and safety of pirenzepine in double-contrast study of upper gastrointestinal tract: comparison with scopolamine methylbromideG Braccini, P Marraccini, A Marrucci, et al.
Blood|January 1, 1989
Prognostic impact of cytogenetic abnormalities in patients with de novo acute nonlymphocytic leukemiaC A Schiffer, E J Lee, T Tomiyasu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1989
Antimycobacterial chemotherapy in inflammatory bowel diseaseA Picciotto, G P Gesu, G C Schito, et al.
Oncogene|June 10, 1998
Akt2 mRNA is highly expressed in embryonic brown fat and the AKT2 kinase is activated by insulinD A Altomare, G E Lyons, Y Mitsuuchi, et al.
Cancer Research|July 14, 1998
Isolation of MOAT-B, a widely expressed multidrug resistance-associated protein/canalicular multispecific organic anion transporter-related transporterK Lee, M G Belinsky, D W Bell, et al.
Journal of Toxicology and Environmental Health. Part B, Critical Reviews|May 3, 2011
Factors that impact susceptibility to fiber-induced health effectsJennifer E Below, Nancy J Cox, Naomi K Fukagawa, et al.
Cancer Research|March 1, 1992
Chromosome alterations in human small cell lung cancer: frequent involvement of 5qI Miura, S L Graziano, J Q Cheng, et al.
Genomics|January 1, 1988
The AKT1 proto-oncogene maps to human chromosome 14, band q32S P Staal, K Huebner, C M Croce, et al.
Therapeutic Drug Monitoring|August 15, 2000
Histologic determinants of monoethylglycinexylidide formation in patients with chronic hepatitis CR Testa, E Giannini, P Ceppa, et al.
Pageof 59

Showing results (191-200 of 588) with videos related to

Sort By:
Pageof 59
Pediatrics|December 1, 1984
Acquired chromosome rearrangements, including fine interstitial deletions, in a patient with Down syndrome and monoblastic leukemiaS Misawa, J R Testa, L C Strauss, et al.
Abdominal Imaging|May 1, 1994
Usefulness and safety of pirenzepine in double-contrast study of upper gastrointestinal tract: comparison with scopolamine methylbromideG Braccini, P Marraccini, A Marrucci, et al.
Blood|January 1, 1989
Prognostic impact of cytogenetic abnormalities in patients with de novo acute nonlymphocytic leukemiaC A Schiffer, E J Lee, T Tomiyasu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1989
Antimycobacterial chemotherapy in inflammatory bowel diseaseA Picciotto, G P Gesu, G C Schito, et al.
Oncogene|June 10, 1998
Akt2 mRNA is highly expressed in embryonic brown fat and the AKT2 kinase is activated by insulinD A Altomare, G E Lyons, Y Mitsuuchi, et al.
Cancer Research|July 14, 1998
Isolation of MOAT-B, a widely expressed multidrug resistance-associated protein/canalicular multispecific organic anion transporter-related transporterK Lee, M G Belinsky, D W Bell, et al.
Journal of Toxicology and Environmental Health. Part B, Critical Reviews|May 3, 2011
Factors that impact susceptibility to fiber-induced health effectsJennifer E Below, Nancy J Cox, Naomi K Fukagawa, et al.
Cancer Research|March 1, 1992
Chromosome alterations in human small cell lung cancer: frequent involvement of 5qI Miura, S L Graziano, J Q Cheng, et al.
Genomics|January 1, 1988
The AKT1 proto-oncogene maps to human chromosome 14, band q32S P Staal, K Huebner, C M Croce, et al.
Therapeutic Drug Monitoring|August 15, 2000
Histologic determinants of monoethylglycinexylidide formation in patients with chronic hepatitis CR Testa, E Giannini, P Ceppa, et al.
Pageof 59